Systemic mastocytosis may present with osteoporosis which improves with bisphosphonates

被引：0
|
作者：
Lim, AYN
Ostor, AJK
Love, SA
Crisp, AJ
机构：
[1] Addenbrookes Hosp, Dept Rheumatol, Cambridge, England
[2] Addenbrookes Hosp, Dept Metab Bone Dis, Cambridge, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：448 / 448
页数：1
相关论文
共 50 条
  • [41] Serum levels of bone cytokines are increased in indolent systemic mastocytosis associated with osteopenia or osteoporosis
    Rabenhorst, Anja
    Christopeit, Bastian
    Leja, Silke
    Gerbaulet, Alexander
    Kleiner, Svea
    Foerster, Anja
    Raap, Ulrike
    Wickenhauser, Claudia
    Hartmann, Karin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (05) : 1234 - 1237
  • [42] Serum levels of bone cytokines in indolent systemic mastocytosis associated with osteopenia or osteoporosis Reply
    Rabenhorst, Anja
    Hartmann, Karin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (03) : 935 - 936
  • [43] Pamidronate is effective in the treatment of osteoporosis in men due to systemic mastocytosis: A prospective, controlled study
    Minne, HW
    Lazarescu, AD
    Pfeifer, R
    Lazarescu, D
    Delling, G
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S190 - S190
  • [44] The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis
    Marshall, A
    Kavanagh, RT
    Crisp, AJ
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (03): : 393 - 396
  • [45] Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations
    Broesby-Olsen, S.
    Vestergaard, H.
    Mortz, C. G.
    Jensen, B.
    Havelund, T.
    Hermann, A. P.
    Siebenhaar, F.
    Moller, M. B.
    Kristensen, T. K.
    Bindslev-Jensen, C.
    ALLERGY, 2018, 73 (01) : 230 - 238
  • [46] Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosis
    Laroche, M.
    Bret, J.
    Brouchet, A.
    Mazieres, B.
    CLINICAL RHEUMATOLOGY, 2007, 26 (02) : 242 - 243
  • [47] Osteoporosis secondary to systemic mastocytosis - A long term follow up study of treatment with pamidronate and aldendronate
    Lim, AYN
    Crisp, AJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (06) : 1173 - 1173
  • [48] Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosis
    M. Laroche
    J. Bret
    A. Brouchet
    B. Mazières
    Clinical Rheumatology, 2007, 26 : 242 - 243
  • [49] Lipid Biomarkers May Be Associated With Osteoporosis in Systemic Lupus Erythematosus
    Au, Karen
    Sahakian, Lori
    Skaggs, Brian
    Grossman, Jennifer
    Fitzgerald, John
    Wallace, Daniel
    Hahn, Bevra
    McMahon, Maureen
    ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 3981 - 3981
  • [50] Histological characteristics and prevalence of secondary osteoporosis in systemic mastocytosis. A retrospective analysis of 158 cases
    Delling, G
    Ritzel, H
    Werner, M
    PATHOLOGE, 2001, 22 (02): : 132 - 140
12345